Vertex Pharmaceutic (VRTX)
485.00 x 1 494.00 x 2
Post-market by (Cboe BZX)
482.30 +9.93 (+2.10%) 04/09/25 [NASDAQ]
485.00 x 1 494.00 x 2
Post-market 494.00 +11.70 (+2.43%) 17:56 ET
for Wed, Apr 9th, 2025
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GILD | BMY | ||
| Company | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 460.02 | 97.97 | 51.20 | ||
| High | 487.15 | 107.46 | 54.05 | ||
| Low | 452.00 | 97.32 | 49.92 | ||
| Last | 482.30 | 105.25 | 53.74 | ||
| Change | +9.93 | +2.06 | +0.67 | ||
| % Change | +2.10% | +2.00% | +1.26% | ||
| Volume | 3,171,300 | 19,222,600 | 24,323,309 | ||
| 20-Day Average Volume | 1,689,090 | 10,685,641 | 12,794,710 | ||
| Previous Close | 472.37 | 103.19 | 53.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 495.84 | 109.17 | 58.72 | ||
| 20-Day Raw Stochastic | 47.75% | 43.70% | 32.59% | ||
| 20-Day Relative Strength | 49.10% | 45.44% | 36.93% | ||
| Weighted Alpha | +17.48 | +54.28 | +9.81 | ||
| Today's Opinion | 40% Buy | 56% Buy | 24% Buy | ||
| Previous Opinion | 40% Buy | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.25% since 04/02/25 | -5.93% since 04/02/25 | -9.83% since 04/02/25 | ||
| Low | 448.14 on 04/07/25 | 97.32 on 04/09/25 | 49.92 on 04/09/25 | ||
| High | 499.07 on 04/04/25 | 114.75 on 04/03/25 | 60.80 on 04/03/25 | ||
| 1-Month | |||||
| %Chg | -1.23% since 03/07/25 | -10.36% since 03/07/25 | -12.03% since 03/07/25 | ||
| Low | 448.14 on 04/07/25 | 97.32 on 04/09/25 | 49.92 on 04/09/25 | ||
| High | 519.68 on 03/14/25 | 119.96 on 03/10/25 | 63.33 on 03/11/25 | ||
| 3-Month | |||||
| %Chg | +17.03% since 01/08/25 | +18.07% since 01/08/25 | -5.40% since 01/08/25 | ||
| Low | 397.24 on 01/13/25 | 88.57 on 01/10/25 | 49.92 on 04/09/25 | ||
| High | 519.68 on 03/14/25 | 119.96 on 03/10/25 | 63.33 on 03/11/25 | ||
| 6-Month | |||||
| %Chg | +3.06% since 10/09/24 | +22.18% since 10/09/24 | +1.78% since 10/09/24 | ||
| Low | 377.85 on 12/19/24 | 84.17 on 10/11/24 | 49.92 on 04/09/25 | ||
| High | 519.88 on 11/08/24 | 119.96 on 03/10/25 | 63.33 on 03/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 121,299,904 | 128,488,368 | 107,984,872 | ||
| Shares Outstanding, K | 256,790 | 1,245,163 | 2,034,763 | ||
| Annual Sales | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 | ||
| Annual Net Income | -535,600,000 | 480,000,000 | -8,948,000,000 | ||
| Last Quarter Sales | 2,912,000,000 | 7,569,000,000 | 12,342,000,000 | ||
| Last Quarter Net Income | 913,000,000 | 1,783,000,000 | 72,000,000 | ||
| 60-Month Beta | 0.50 | 0.32 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.98 on 02/10/25 | 1.90 on 02/11/25 | 1.67 on 02/06/25 | ||
| Latest Earnings Date | 05/05/25 | 04/24/25 | 04/24/25 | ||
| Most Recent Dividend | N/A | 0.790 on 03/14/25 | 0.620 on 04/04/25 | ||
| Next Ex-Dividends Date | N/A | 03/14/25 | 04/04/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.89 | 48.41 | ||